DK3439668T3 - Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose - Google Patents
Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose Download PDFInfo
- Publication number
- DK3439668T3 DK3439668T3 DK17779973.1T DK17779973T DK3439668T3 DK 3439668 T3 DK3439668 T3 DK 3439668T3 DK 17779973 T DK17779973 T DK 17779973T DK 3439668 T3 DK3439668 T3 DK 3439668T3
- Authority
- DK
- Denmark
- Prior art keywords
- small molecule
- cystic fibrosis
- airway surface
- human cystic
- lung epithelia
- Prior art date
Links
- 201000003883 Cystic fibrosis Diseases 0.000 title 1
- 210000004072 lung Anatomy 0.000 title 1
- 230000035479 physiological effects, processes and functions Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662320111P | 2016-04-08 | 2016-04-08 | |
| US201662320795P | 2016-04-11 | 2016-04-11 | |
| PCT/US2017/026806 WO2017177228A1 (en) | 2016-04-08 | 2017-04-10 | Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3439668T3 true DK3439668T3 (da) | 2024-09-02 |
Family
ID=60001496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17779973.1T DK3439668T3 (da) | 2016-04-08 | 2017-04-10 | Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20190083517A1 (https=) |
| EP (1) | EP3439668B1 (https=) |
| JP (1) | JP7041961B2 (https=) |
| AU (1) | AU2017248394B2 (https=) |
| DK (1) | DK3439668T3 (https=) |
| ES (1) | ES2983639T3 (https=) |
| FI (1) | FI3439668T3 (https=) |
| PT (1) | PT3439668T (https=) |
| WO (1) | WO2017177228A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3439668B1 (en) | 2016-04-08 | 2024-06-19 | The Board of Trustees of the University of Illinois | Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia |
| FI3694526T3 (fi) | 2017-10-11 | 2025-02-06 | Univ Illinois | Genotyypistä riippumaton toimintakyvyn palautus pienimolekyylisillä bikarbonaattikanavilla kystistä fibroosia varten |
| IL315719A (en) | 2022-03-21 | 2024-11-01 | Univ Illinois | Prosthetic assemblies of ion channels containing lipid-coated amphotericin B crystals |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4906476A (en) * | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
| JP3507486B2 (ja) | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| CA2194049A1 (en) | 1994-06-28 | 1996-01-11 | Georgi Stankov | Novel clinical uses of polyene macrolides |
| TWI249408B (en) * | 2003-12-10 | 2006-02-21 | Ind Tech Res Inst | New antifungal formulation and manufacturing method thereof |
| AU2005251745A1 (en) * | 2004-06-04 | 2005-12-22 | The Regents Of The University Of California | Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof |
| HUE031951T2 (en) | 2006-10-10 | 2017-08-28 | Jina Pharmaceuticals Inc | Aqueous systems for lipid-based drug compounds; preparations, processes and their use |
| WO2009006311A2 (en) * | 2007-06-29 | 2009-01-08 | Wisconsin Alumni Research Foundation | Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals |
| EP2488160B1 (en) * | 2009-10-16 | 2020-07-01 | Lifecare Innovations Pvt. Ltd. | Liposomal amphotericin formulation comprising cholesterol for treating fungal infections |
| KR102548341B1 (ko) * | 2013-10-07 | 2023-06-26 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 개선된 치료 지수를 갖는 암포테리신 b 유도체 |
| JP6796581B2 (ja) * | 2014-11-04 | 2020-12-09 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ | ミッシングタンパク質の小分子模倣体を用いた生理機能の回復 |
| EP3439668B1 (en) | 2016-04-08 | 2024-06-19 | The Board of Trustees of the University of Illinois | Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia |
-
2017
- 2017-04-10 EP EP17779973.1A patent/EP3439668B1/en active Active
- 2017-04-10 US US16/091,599 patent/US20190083517A1/en not_active Abandoned
- 2017-04-10 ES ES17779973T patent/ES2983639T3/es active Active
- 2017-04-10 FI FIEP17779973.1T patent/FI3439668T3/fi active
- 2017-04-10 PT PT177799731T patent/PT3439668T/pt unknown
- 2017-04-10 DK DK17779973.1T patent/DK3439668T3/da active
- 2017-04-10 JP JP2018552659A patent/JP7041961B2/ja active Active
- 2017-04-10 AU AU2017248394A patent/AU2017248394B2/en active Active
- 2017-04-10 WO PCT/US2017/026806 patent/WO2017177228A1/en not_active Ceased
-
2021
- 2021-06-01 US US17/335,803 patent/US11850256B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20210393661A1 (en) | 2021-12-23 |
| EP3439668A1 (en) | 2019-02-13 |
| AU2017248394A1 (en) | 2018-11-22 |
| FI3439668T3 (fi) | 2024-09-05 |
| EP3439668B1 (en) | 2024-06-19 |
| JP7041961B2 (ja) | 2022-03-25 |
| PT3439668T (pt) | 2024-08-12 |
| JP2019510788A (ja) | 2019-04-18 |
| US20190083517A1 (en) | 2019-03-21 |
| US11850256B2 (en) | 2023-12-26 |
| EP3439668A4 (en) | 2019-12-18 |
| WO2017177228A1 (en) | 2017-10-12 |
| AU2017248394B2 (en) | 2023-02-23 |
| ES2983639T3 (es) | 2024-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261987B (en) | Modulators of cystic fibrosis transmembrane conductance regulator | |
| IL263030A (en) | Pegylated liposomes and methods of use | |
| DK3929207T3 (da) | Peptid fttftvt til anvendelse i behandling af fibrose | |
| EP3091955A4 (en) | Portable massage roller | |
| HUE055369T2 (hu) | Gyógyászati készítmények cisztás fibrózis transzmembrán konduktancia regulátor kövzetítette betegségek kezelésére | |
| BR112015023328A2 (pt) | compostos de piridazinona e métodos para o tratamento de fibrose cística | |
| HUE073236T2 (hu) | Aromainhalátor | |
| IL258227A (en) | Vertical-cavity surface-emitting laser thin wafer bowing control | |
| HRP20241144T8 (hr) | Stabilne formulacije lipida i lipozoma | |
| PL4209238T3 (pl) | Nebulizator oraz wkład | |
| EP3425259A4 (en) | PRESSURE RESERVOIR AND TRANSFORMER CONTAINER | |
| EP3379337A4 (en) | Conductive roll | |
| GB2551124B (en) | Improvements in and relating to network configuration | |
| DK3149153T3 (da) | Forøgelse af lipidproduktion i olieholdig gær | |
| EP3358075A4 (en) | FOIL AND LAMINATE BODY | |
| EP3178461A4 (en) | Ultra-thin massaging core and massager using same | |
| EP3189472A4 (en) | Managing registration of user identity using handwriting | |
| IL253607A0 (en) | A powerful interferometer and methods of using it | |
| EP3307898A4 (en) | CELLULOSIC BIOFUEL AND BY-PRODUCTS | |
| DK3116570T3 (da) | Inhalator | |
| MA42266A (fr) | Agent thérapeutique contre la fibrose | |
| PL3443854T3 (pl) | Inhalator aromatu | |
| EP3513970A4 (en) | HARD COATING COMPOSITE FILM | |
| DK3439668T3 (da) | Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose | |
| FR3052670B3 (fr) | Nebuliseur |